✦ LIBER ✦

Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial

✍ Scribed by Sean P. Donahue; Franco Recchia; Paul Sternberg Jr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab vs Ranibizumab for Age-Relat

✍ Manju L. Subramanian; Steven Ness; Gelareh Abedi; Ednan Ahmed; Mary Daly; Edward 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Bevacizumab vs ranibizumab for age-relat

✍ Subramanian, M L; Abedi, G; Ness, S; Ahmed, E; Fenberg, M; Daly, M K; Houranieh, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 330 KB

Randomized Study of Bevacizumab vs Ranib

✍ Andrea Messori; Valeria Fadda; Sabrina Trippoli 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Ranibizumab versus Bevacizumab for Neova

✍ Kodjikian, Laurent; Souied, Eric H.; Mimoun, Gérard; Mauget-Faÿsse, Martine; Beh 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 770 KB

Randomized, Double-Masked, Sham-Controll

✍ Carl D. Regillo; David M. Brown; Prema Abraham; Huibin Yue; Tsontcho Ianchulev; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 856 KB

Bevacizumab for neovascular age related

✍ Adnan Tufail, Praveen J Patel, Catherine Egan, Philip Hykin, Lyndon da Cruz, Zde 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 311 KB